Clocks out of sync: Increased epigenetic aging variability in multiple sclerosis

Read full text Summarise with VIRAT
Authors: Fernanda Lang Schumacher, Gary Cutter, Christin Elizabeth Burd, Kellie J. Archer, Yinan Zhang
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Epigenetic clocks are composite measures of DNA methylation used as markers of biological age. This study found that epigenetic age acceleration (EAA) exhibits greater variability in individuals with multiple sclerosis (MS) compared to sex- and age-matched healthy controls (HC). Specifically, the standard deviation for PhenoAge in the secondary progressive (SP) MS group was 12.7, which is 1.5 times that of controls. A likelihood ratio test confirmed a significant difference in variance across relapsing remitting (RR) MS, SPMS, and HC groups, with a p-value of 0.017. This heterogeneity suggests future epigenetic aging studies in MS will require larger sample sizes and underscore the need for variance-aware sample size planning.

Fields of Study & Subjects

Multiple Sclerosis Research Studies Epigenetics and DNA Methylation Genetics Aging and Longevity in Model Organisms

Publication details

Journal / source
Journal of the Neurological Sciences
Volume
485
Pages
125904–125904
Publication date
31 March 2026
Language
EN